folate receptor beta CAR-T

N/A

Report date: 2025/03/20 15:10:39

Base Information

Drug Namefolate receptor beta CAR-T
Drug Alias Nameanti-folate receptor beta CAR T-cell therapy (Kite Pharma)anti-folate receptor beta CAR T-cell therapy (Tmunity)
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionFolate receptor beta modulators
TargetsFolate receptor beta
Therapy Area/IndicationsSolid tumoursLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTmunity Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKite Pharma Inc
Inactive CompaniesTmunity Therapeutics Inc
Active IndicationsSolid tumoursLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A